Efficacy of Ublituximab in People with Highly Active Relapsing Multiple Sclerosis

20260 citationsJournal Articlegold Open Access

Authors

Hans-Peter Hartung · The University of Sydney

Derrick Robertson · University of South Florida

Lawrence Steinman · Stanford University

Douglas N. Arnold · NeuroRx Research (Canada)

Peiqing Qian · Swedish Medical Center

Sibyl Wray · HOPE Clinic

Edward J. Fox ·

Abstract

Clinical trial registry: ULTIMATE I and II ClinicalTrials.gov numbers, NCT03277261 (registration date September 7, 2017) and NCT03277248 (registration date September 7, 2017).

Topics & Keywords

Multiple Sclerosis Research Studies Peripheral Neuropathies and Disorders Rheumatoid Arthritis Research and Therapies

Publication Details

Published in: Neurology and Therapy

DOI: 10.1007/s40120-026-00904-4

Field-Weighted Citation Impact: 0.00

Command Palette

Efficacy of Ublituximab in People with Highly Active Relapsing Multiple Sclerosis

Authors

Abstract

Topics & Keywords

Publication Details